Vancomycin bioequivalence standards face US panel scrutiny
This article was originally published in Scrip
Executive Summary
The US FDA's advisory panel for pharmaceutical science and clinical pharmacology will convene on August 4th to discuss bioequivalence recommendations for oral vancomycin HCl capsule products.